Sentynyl Therapeutics, Inc. vs. Concordia Systems, Inc. – Trademark Cancellation TTAB Proceeding 92081168

This Cancellation was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on December 09, 2022 and assigned serial number 92081168 by the TTAB.

Plaintiff:
Sentynyl Therapeutics, Inc. represented by STEPHANIE ALVAREZ of HOLLEY & MENKER, P.A..

Defendant:
Concordia Systems, Inc. represented by of CONCORDIA SYSTEMS INC.
Trademark Information: SENTINELCARE – US Trademark Serial Number 87105347
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
December 09, 2022 – FILED AND FEE
December 09, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
December 09, 2022 – INSTITUTED
January 29, 2023 – NOTICE OF DEFAULT
March 10, 2023 – BD DECISION: CAN GRANTED
April 20, 2023 – REFUND IN PROCESS – TRADEMARK RULE 2.114(a)(2)
April 20, 2023 – REFUND ISSUED – TRADEMARK RULE 2.114(A)(2)
April 20, 2023 – COMMR ORDER CANCELLING REG
April 20, 2023 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *